News

Patients are already receiving the new PrEP injectable option lenacapavir in the Bay Area, though issues with insurance are ...
Conference on HIV Science (IAS 2025) concluded in Kigali after five dynamic days (July 13-17), delegates left with a mix of hope and concern--buoyed by scientific breakthroughs but unsettled by a ...
South Africa has the world’s largest HIV treatment programme, with over 5. 5 million people receiving antiretrovirals (ARVs).
The initiative will include the production of the newly approved injectable drug for HIV prevention – Lenacapavir ...
Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...